DIDACTIC acquired by UI INVESTISSEMENT
Context
Didactic reorganized its shareholder base to accelerate its transformation into a European industrial leader. GENEO Capital Entrepreneur and UI Investissement acquired a majority stake, taking over from the previous sponsor. The transaction involves significant reinvestment from the President and his management team, alongside Bpifrance and MACSF.
DIDACTIC, which reported an EBITDA margin of [members only] in 2023, is valued in this transaction at an EV/EBITDA multiple of [members only], to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Founded in 1967, Didactic is a leading French player in the design, manufacture, and distribution of medical devices, specifically dedicated to infectious risk management and perfusion. As the market leader in examination gloves and the number two player in medical hygiene in France, Didactic supplies over 4,000 clients, primarily public hospitals and private clinics.
Ent. Value
€50–100M
Equity Value
[members only]
Multiples
EV / Revenue
[members only]
EV / EBITDA
[members only]
EV / EBIT
[members only]
Historical Financials (EUR)
Similar deals in Life Sciences
Similar deals in Life Sciences
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 01/2025 | Animalcare Group | Randlab | AUSTRALIA | Animal Health |
| 01/2025 | QUADRIVIO GROUP | MIR - MEDICAL INTERNATIONAL RESEARCH | ITALY | Diagnostic Equipment |
| 12/2024 | GOLDMAN SACHS | Synthon International | NETHERLANDS | Generics / Labs |
| 12/2024 | NEXTSTAGE / IK PARTNERS | EUROBIO SCIENTIFIC | FRANCE | Diagnostic Equipment |
| 11/2024 | NAXICAP PARTNERS | GLOBAL D | FRANCE | Implants & Prosthetics |
| 10/2024 | KKR / KREFELD | ANJAC BEAUTY & HEALTH | FRANCE | CDMO |
| 10/2024 | CLAYTON, DUBILIER & RICE (CD&R) | OPELLA | FRANCE | Generics / Labs |
| 10/2024 | BANSK GROUP | PETIQ | UNITED STATES | Animal Health |
| 09/2024 | AGILENT TECHNOLOGIES | BIOVECTRA | CANADA | CDMO |
| 08/2024 | RECURSION PHARMACEUTICALS | EXSCIENTIA | UNITED KINGDOM | R&D Biotech |
Other operations with UI INVESTISSEMENT
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 09/2026 | UI INVESTISSEMENT | Finasens | FRANCE | Accounting & Audit |
| 01/2026 | UI INVESTISSEMENT | MAISON ALSACIENNE DE BISCUITERIE | FRANCE | Fine Food / Organic |
| 07/2025 | UI INVESTISSEMENT / MACSF / COVEA | ADIT (AGENCE POUR LA DIFFUSION DE L'INFORMATION TECHNOLOGIQUE) | FRANCE | Consulting & Audit |
| 11/2024 | UI INVESTISSEMENT | ANTARES DIFFUSION | FRANCE | Aftermarket & Repair |
| 06/2022 | UI INVESTISSEMENT / GENEO | NEFTYS PHARMA | FRANCE | Animal Health |
| 10/2017 | UI INVESTISSEMENT / BPIFRANCE | THERADIAL | FRANCE | Medical Devices |
| 01/2015 | UI INVESTISSEMENT | GAULT & FRÉMONT | FRANCE | Paper & Cardboard |
REFERENCES
Revenue range: €50–100M
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of DIDACTIC by UI INVESTISSEMENT are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Acquirer: ui investissement